CLICK HERE FOR VIDEO
A Wall Street Journal report suggested the company's arthritis shots, Librela and Solensia, could have sickened dogs and cats.
The shots, which gained Food and Drug Administration approval in 2022 and 2023, respectively, are the first antibody drugs for pets.
They treat osteoarthritis by targeting a protein called nerve growth factor. But vets say that could exacerbate underlying nerve conditions or other medical problems.
A Wall Street Journal article is reporting that pet owners are blaming Zoetis medication for their pets' side effects, even death.
However, Zoetis claims their medication is safe. The video mentions that health regulators are investigating the drugs. People who have pets that experienced side effects after taking Zoetis medication are encouraged to come forward in the comments.